Ardelyx Inc (NASDAQ: ARDX) on Monday, soared 2.67% from the previous trading day, before settling in for the closing price of $4.49. Within the past 52 weeks, ARDX’s price has moved between $3.21 and $7.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 35.34% over the past five years. The company achieved an average annual earnings per share of -133.71%. With a float of $230.36 million, this company’s outstanding shares have now reached $239.20 million.
Let’s look at the performance matrix of the company that is accounted for 395 employees. In terms of profitability, gross margin is 85.08%, operating margin of -10.95%, and the pretax margin is -14.59%.
Ardelyx Inc (ARDX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ardelyx Inc is 3.72%, while institutional ownership is 71.21%. The most recent insider transaction that took place on Jun 16 ’25, was worth 725,880. In this transaction Director of this company bought 200,000 shares at a rate of $3.63, taking the stock ownership to the 2,896,871 shares. Before that another transaction happened on Jun 09 ’25, when Company’s Director bought 200,000 for $3.69, making the entire transaction worth $737,260. This insider now owns 2,696,871 shares in total.
Ardelyx Inc (ARDX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -133.71% per share during the next fiscal year.
Ardelyx Inc (NASDAQ: ARDX) Trading Performance Indicators
Ardelyx Inc (ARDX) is currently performing well based on its current performance indicators. A quick ratio of 3.81 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.23, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach 0.06 in one year’s time.
Technical Analysis of Ardelyx Inc (ARDX)
Ardelyx Inc (NASDAQ: ARDX) saw its 5-day average volume 6.13 million, a positive change from its year-to-date volume of 4.9 million. As of the previous 9 days, the stock’s Stochastic %D was 88.30%.
During the past 100 days, Ardelyx Inc’s (ARDX) raw stochastic average was set at 41.92%, which indicates a significant decrease from 90.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was lower than the 0.26 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.90, while its 200-day Moving Average is $5.01. Nevertheless, the first resistance level for the watch stands at $4.77 in the near term. At $4.93, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.14. If the price goes on to break the first support level at $4.39, it is likely to go to the next support level at $4.18. Assuming the price breaks the second support level, the third support level stands at $4.02.
Ardelyx Inc (NASDAQ: ARDX) Key Stats
Market capitalization of the company is 1.10 billion based on 239,255K outstanding shares. Right now, sales total 333,620 K and income totals -39,140 K. The company made 74,110 K in profit during its latest quarter, and -41,140 K in sales during its previous quarter.
